Effect of peroxisome proliferator-activated receptor γ agonist rosiglitazone on intestinal injury in rats undergoing orthotopic autologous liver transplantation by inhibiting inflammatory response
CHENG Nan1, CHI Xin-jin1, LI Xi2, GE Mian1, GAO Wan-ling1, HEI Zi-qing1
1. Department of Anesthesiology, Third Affiliated Hospital, Sun Yat-sen University, Guangzhou 510630, China;
2. Department of Thyroid and Breast Surgery, Third Affiliated Hospital, Sun Yat-sen University, Guangzhou 510630, China
AIM: To investigate the effect of rosiglitazone, a peroxisome proliferators-activated receptor γ(PPARγ) agonist, on the expression of PPARγ, the activation of NF-κB and intestine injury in the rats undergoing orthotopic autologous liver transplantation(OALT).METHODS: Sprague-Dawley male rats were randomly divided into 4 groups:control group, sham group, OALT group and rosiglitazone(0.3 mg/kg, iv) pretreatment(ROS+OALT) group. The OALT model was established, and the intestinal tissues were collected 8 h after the liver reperfusion. The intestinal tissue sections were stained to visualize the damage. The expression of PPARγ and NF-κB in the tissues, the concentrations of diamine oxidase(DAO) and fatty acid-binding protein 2(FABP2) in the serum and the concentration of TNF-α and IL-6 in the tissues were measured.RESULTS: Compared with sham group, the intestinal mucosa of the rats showed obvious pathological injury after liver reperfusion in OALT group and ROS group, the Chiu,s scores of intestinal mucosa was significantly higher, and the serum concentrations of DAO and FABP2 increased(P<0.05). After rosiglitazone pretreatment, the injury of intestinal mucosa of the rats was alleviated, the Chiu,s scores was lower and the serum concentrations of DAO and FABP2 decreased(P<0.05), the PPARγ expression was obviously up-regulated in the intestinal tissues, the nuclear translocation of NF-κB was reduced and the concentrations of IL-6 and TNF-α were decreased.CONCLUSION: During perioperative period of OALT in rats, the inflammatory responses are obvious. Furthermore, obvious intestinal injury occurs. PPARγ agonist rosiglitazone obviously up-regulates PPARγ expression and inhibits the inflammation in the intestines, thus protecting against intestinal injury in rats undergoing OALT.
Zhang K, Jiao XF, Li JX, et al. Rhein inhibits lipopolysaccharide-induced intestinal injury during sepsis by blocking the toll-like receptor 4 nuclear factor-κB pathway[J]. Mol Med Rep,2015,12(3):4415-4421.
[2]
Ma T, Ma ZQ, Du XH, et al. Effect of valsartan on ACAT-1 and PPAR-γ expression in intima with carotid artery endothelial balloon injury in rabbit[J].Int J Clin Exp Med,2015,8(4):5527-5533.
[3]
Chi X, Zhang A, Luo G, et al. Knockdown of myeloid differentiation protein-2 reduces acute lung injury following orthotopic autologous liver transplantation in a rat model[J]. Pulm Pharmacol Ther,2013,26(3):380-387.
Albillos A, De la Hera A. Multifactorial gut barrier failure in cirrhosis and bacterial translocation:working out the role of probiotics and antioxidants[J]. Hepato, 2002,37(4):523-526.
[8]
Johnston TD, Fischer R, Chen Y, et al. Lung injury from gut ischemia:insensitivity to portal blood flow diversion[J]. Trauma,1993,35(4):508- 511.
Cuzzocrea S, Pisano B, Dugo L, et al. Rosiglitazone,a ligand of the peroxisome proliferator-activated receptor-γ, reduces the development of nonseptic shock induced by zymosan in mice[J]. Crit Care Med,2004,32(2):457-466.
[11]
Kim MG, Yong HN, Kim HW, et al. IL-10 mediates ro-siglitazone induced kidney protection in cisplatin nephroto-xicity[J]. Korean Med Sci, 2010, 25(4):557-563.
[12]
Moriyama K, Kouchi Y, Morinaga H, et al. Diamine oxidase, a plasma biomarker in rats to GI tract toxicity of oral fluorouracil anti-cancer drugs[J]. Toxicology,2006,217(2-3):233-239.
